Request for Covid-19 Impact Assessment of this Report
The United States Herpes Zoste Drug market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Herpes Zoste Drug market, reaching US$ million by the year 2028. As for the Europe Herpes Zoste Drug landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Herpes Zoste Drug players cover Astellas Pharma Inc., Beijing Minhai Biotechnology Co., Ltd, ContraVir Pharmaceuticals, Inc., and Epiphany Biosciences, Inc., etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Herpes Zoste Drug market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Acyclovir
Amenamevir
FV-100
GLS-5100
GSK-1437173A
NAL-3221
Others
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Clinic
Hospital
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Astellas Pharma Inc.
Beijing Minhai Biotechnology Co., Ltd
ContraVir Pharmaceuticals, Inc.
Epiphany Biosciences, Inc.
Foamix Pharmaceuticals Ltd.
GeneOne Life Science, Inc.
GlaxoSmithKline Plc
Merck & Co., Inc.
NAL Pharmaceuticals Ltd.
ReceptoPharm, Inc.
TSRL, Inc.
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Herpes Zoste Drug Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Herpes Zoste Drug by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Herpes Zoste Drug by Country/Region, 2017, 2022 & 2028
2.2 Herpes Zoste Drug Segment by Type
2.2.1 Acyclovir
2.2.2 Amenamevir
2.2.3 FV-100
2.2.4 GLS-5100
2.2.5 GSK-1437173A
2.2.6 NAL-3221
2.2.7 Others
2.3 Herpes Zoste Drug Sales by Type
2.3.1 Global Herpes Zoste Drug Sales Market Share by Type (2017-2022)
2.3.2 Global Herpes Zoste Drug Revenue and Market Share by Type (2017-2022)
2.3.3 Global Herpes Zoste Drug Sale Price by Type (2017-2022)
2.4 Herpes Zoste Drug Segment by Application
2.4.1 Clinic
2.4.2 Hospital
2.4.3 Others
2.5 Herpes Zoste Drug Sales by Application
2.5.1 Global Herpes Zoste Drug Sale Market Share by Application (2017-2022)
2.5.2 Global Herpes Zoste Drug Revenue and Market Share by Application (2017-2022)
2.5.3 Global Herpes Zoste Drug Sale Price by Application (2017-2022)
3 Global Herpes Zoste Drug by Company
3.1 Global Herpes Zoste Drug Breakdown Data by Company
3.1.1 Global Herpes Zoste Drug Annual Sales by Company (2020-2022)
3.1.2 Global Herpes Zoste Drug Sales Market Share by Company (2020-2022)
3.2 Global Herpes Zoste Drug Annual Revenue by Company (2020-2022)
3.2.1 Global Herpes Zoste Drug Revenue by Company (2020-2022)
3.2.2 Global Herpes Zoste Drug Revenue Market Share by Company (2020-2022)
3.3 Global Herpes Zoste Drug Sale Price by Company
3.4 Key Manufacturers Herpes Zoste Drug Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Herpes Zoste Drug Product Location Distribution
3.4.2 Players Herpes Zoste Drug Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Herpes Zoste Drug by Geographic Region
4.1 World Historic Herpes Zoste Drug Market Size by Geographic Region (2017-2022)
4.1.1 Global Herpes Zoste Drug Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Herpes Zoste Drug Annual Revenue by Geographic Region
4.2 World Historic Herpes Zoste Drug Market Size by Country/Region (2017-2022)
4.2.1 Global Herpes Zoste Drug Annual Sales by Country/Region (2017-2022)
4.2.2 Global Herpes Zoste Drug Annual Revenue by Country/Region
4.3 Americas Herpes Zoste Drug Sales Growth
4.4 APAC Herpes Zoste Drug Sales Growth
4.5 Europe Herpes Zoste Drug Sales Growth
4.6 Middle East & Africa Herpes Zoste Drug Sales Growth
5 Americas
5.1 Americas Herpes Zoste Drug Sales by Country
5.1.1 Americas Herpes Zoste Drug Sales by Country (2017-2022)
5.1.2 Americas Herpes Zoste Drug Revenue by Country (2017-2022)
5.2 Americas Herpes Zoste Drug Sales by Type
5.3 Americas Herpes Zoste Drug Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Herpes Zoste Drug Sales by Region
6.1.1 APAC Herpes Zoste Drug Sales by Region (2017-2022)
6.1.2 APAC Herpes Zoste Drug Revenue by Region (2017-2022)
6.2 APAC Herpes Zoste Drug Sales by Type
6.3 APAC Herpes Zoste Drug Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Herpes Zoste Drug by Country
7.1.1 Europe Herpes Zoste Drug Sales by Country (2017-2022)
7.1.2 Europe Herpes Zoste Drug Revenue by Country (2017-2022)
7.2 Europe Herpes Zoste Drug Sales by Type
7.3 Europe Herpes Zoste Drug Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Herpes Zoste Drug by Country
8.1.1 Middle East & Africa Herpes Zoste Drug Sales by Country (2017-2022)
8.1.2 Middle East & Africa Herpes Zoste Drug Revenue by Country (2017-2022)
8.2 Middle East & Africa Herpes Zoste Drug Sales by Type
8.3 Middle East & Africa Herpes Zoste Drug Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Herpes Zoste Drug
10.3 Manufacturing Process Analysis of Herpes Zoste Drug
10.4 Industry Chain Structure of Herpes Zoste Drug
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Herpes Zoste Drug Distributors
11.3 Herpes Zoste Drug Customer
12 World Forecast Review for Herpes Zoste Drug by Geographic Region
12.1 Global Herpes Zoste Drug Market Size Forecast by Region
12.1.1 Global Herpes Zoste Drug Forecast by Region (2023-2028)
12.1.2 Global Herpes Zoste Drug Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Herpes Zoste Drug Forecast by Type
12.7 Global Herpes Zoste Drug Forecast by Application
13 Key Players Analysis
13.1 Astellas Pharma Inc.
13.1.1 Astellas Pharma Inc. Company Information
13.1.2 Astellas Pharma Inc. Herpes Zoste Drug Product Offered
13.1.3 Astellas Pharma Inc. Herpes Zoste Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Astellas Pharma Inc. Main Business Overview
13.1.5 Astellas Pharma Inc. Latest Developments
13.2 Beijing Minhai Biotechnology Co., Ltd
13.2.1 Beijing Minhai Biotechnology Co., Ltd Company Information
13.2.2 Beijing Minhai Biotechnology Co., Ltd Herpes Zoste Drug Product Offered
13.2.3 Beijing Minhai Biotechnology Co., Ltd Herpes Zoste Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Beijing Minhai Biotechnology Co., Ltd Main Business Overview
13.2.5 Beijing Minhai Biotechnology Co., Ltd Latest Developments
13.3 ContraVir Pharmaceuticals, Inc.
13.3.1 ContraVir Pharmaceuticals, Inc. Company Information
13.3.2 ContraVir Pharmaceuticals, Inc. Herpes Zoste Drug Product Offered
13.3.3 ContraVir Pharmaceuticals, Inc. Herpes Zoste Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 ContraVir Pharmaceuticals, Inc. Main Business Overview
13.3.5 ContraVir Pharmaceuticals, Inc. Latest Developments
13.4 Epiphany Biosciences, Inc.
13.4.1 Epiphany Biosciences, Inc. Company Information
13.4.2 Epiphany Biosciences, Inc. Herpes Zoste Drug Product Offered
13.4.3 Epiphany Biosciences, Inc. Herpes Zoste Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Epiphany Biosciences, Inc. Main Business Overview
13.4.5 Epiphany Biosciences, Inc. Latest Developments
13.5 Foamix Pharmaceuticals Ltd.
13.5.1 Foamix Pharmaceuticals Ltd. Company Information
13.5.2 Foamix Pharmaceuticals Ltd. Herpes Zoste Drug Product Offered
13.5.3 Foamix Pharmaceuticals Ltd. Herpes Zoste Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Foamix Pharmaceuticals Ltd. Main Business Overview
13.5.5 Foamix Pharmaceuticals Ltd. Latest Developments
13.6 GeneOne Life Science, Inc.
13.6.1 GeneOne Life Science, Inc. Company Information
13.6.2 GeneOne Life Science, Inc. Herpes Zoste Drug Product Offered
13.6.3 GeneOne Life Science, Inc. Herpes Zoste Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 GeneOne Life Science, Inc. Main Business Overview
13.6.5 GeneOne Life Science, Inc. Latest Developments
13.7 GlaxoSmithKline Plc
13.7.1 GlaxoSmithKline Plc Company Information
13.7.2 GlaxoSmithKline Plc Herpes Zoste Drug Product Offered
13.7.3 GlaxoSmithKline Plc Herpes Zoste Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 GlaxoSmithKline Plc Main Business Overview
13.7.5 GlaxoSmithKline Plc Latest Developments
13.8 Merck & Co., Inc.
13.8.1 Merck & Co., Inc. Company Information
13.8.2 Merck & Co., Inc. Herpes Zoste Drug Product Offered
13.8.3 Merck & Co., Inc. Herpes Zoste Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Merck & Co., Inc. Main Business Overview
13.8.5 Merck & Co., Inc. Latest Developments
13.9 NAL Pharmaceuticals Ltd.
13.9.1 NAL Pharmaceuticals Ltd. Company Information
13.9.2 NAL Pharmaceuticals Ltd. Herpes Zoste Drug Product Offered
13.9.3 NAL Pharmaceuticals Ltd. Herpes Zoste Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 NAL Pharmaceuticals Ltd. Main Business Overview
13.9.5 NAL Pharmaceuticals Ltd. Latest Developments
13.10 ReceptoPharm, Inc.
13.10.1 ReceptoPharm, Inc. Company Information
13.10.2 ReceptoPharm, Inc. Herpes Zoste Drug Product Offered
13.10.3 ReceptoPharm, Inc. Herpes Zoste Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 ReceptoPharm, Inc. Main Business Overview
13.10.5 ReceptoPharm, Inc. Latest Developments
13.11 TSRL, Inc.
13.11.1 TSRL, Inc. Company Information
13.11.2 TSRL, Inc. Herpes Zoste Drug Product Offered
13.11.3 TSRL, Inc. Herpes Zoste Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 TSRL, Inc. Main Business Overview
13.11.5 TSRL, Inc. Latest Developments
14 Research Findings and Conclusion
Table 1. Herpes Zoste Drug Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Herpes Zoste Drug Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Acyclovir
Table 4. Major Players of Amenamevir
Table 5. Major Players of FV-100
Table 6. Major Players of GLS-5100
Table 7. Major Players of GSK-1437173A
Table 8. Major Players of NAL-3221
Table 9. Major Players of Others
Table 10. Global Herpes Zoste Drug Sales by Type (2017-2022) & (K Pcs)
Table 11. Global Herpes Zoste Drug Sales Market Share by Type (2017-2022)
Table 12. Global Herpes Zoste Drug Revenue by Type (2017-2022) & ($ million)
Table 13. Global Herpes Zoste Drug Revenue Market Share by Type (2017-2022)
Table 14. Global Herpes Zoste Drug Sale Price by Type (2017-2022) & (USD/Pcs)
Table 15. Global Herpes Zoste Drug Sales by Application (2017-2022) & (K Pcs)
Table 16. Global Herpes Zoste Drug Sales Market Share by Application (2017-2022)
Table 17. Global Herpes Zoste Drug Revenue by Application (2017-2022)
Table 18. Global Herpes Zoste Drug Revenue Market Share by Application (2017-2022)
Table 19. Global Herpes Zoste Drug Sale Price by Application (2017-2022) & (USD/Pcs)
Table 20. Global Herpes Zoste Drug Sales by Company (2020-2022) & (K Pcs)
Table 21. Global Herpes Zoste Drug Sales Market Share by Company (2020-2022)
Table 22. Global Herpes Zoste Drug Revenue by Company (2020-2022) ($ Millions)
Table 23. Global Herpes Zoste Drug Revenue Market Share by Company (2020-2022)
Table 24. Global Herpes Zoste Drug Sale Price by Company (2020-2022) & (USD/Pcs)
Table 25. Key Manufacturers Herpes Zoste Drug Producing Area Distribution and Sales Area
Table 26. Players Herpes Zoste Drug Products Offered
Table 27. Herpes Zoste Drug Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 28. New Products and Potential Entrants
Table 29. Mergers & Acquisitions, Expansion
Table 30. Global Herpes Zoste Drug Sales by Geographic Region (2017-2022) & (K Pcs)
Table 31. Global Herpes Zoste Drug Sales Market Share Geographic Region (2017-2022)
Table 32. Global Herpes Zoste Drug Revenue by Geographic Region (2017-2022) & ($ millions)
Table 33. Global Herpes Zoste Drug Revenue Market Share by Geographic Region (2017-2022)
Table 34. Global Herpes Zoste Drug Sales by Country/Region (2017-2022) & (K Pcs)
Table 35. Global Herpes Zoste Drug Sales Market Share by Country/Region (2017-2022)
Table 36. Global Herpes Zoste Drug Revenue by Country/Region (2017-2022) & ($ millions)
Table 37. Global Herpes Zoste Drug Revenue Market Share by Country/Region (2017-2022)
Table 38. Americas Herpes Zoste Drug Sales by Country (2017-2022) & (K Pcs)
Table 39. Americas Herpes Zoste Drug Sales Market Share by Country (2017-2022)
Table 40. Americas Herpes Zoste Drug Revenue by Country (2017-2022) & ($ Millions)
Table 41. Americas Herpes Zoste Drug Revenue Market Share by Country (2017-2022)
Table 42. Americas Herpes Zoste Drug Sales by Type (2017-2022) & (K Pcs)
Table 43. Americas Herpes Zoste Drug Sales Market Share by Type (2017-2022)
Table 44. Americas Herpes Zoste Drug Sales by Application (2017-2022) & (K Pcs)
Table 45. Americas Herpes Zoste Drug Sales Market Share by Application (2017-2022)
Table 46. APAC Herpes Zoste Drug Sales by Region (2017-2022) & (K Pcs)
Table 47. APAC Herpes Zoste Drug Sales Market Share by Region (2017-2022)
Table 48. APAC Herpes Zoste Drug Revenue by Region (2017-2022) & ($ Millions)
Table 49. APAC Herpes Zoste Drug Revenue Market Share by Region (2017-2022)
Table 50. APAC Herpes Zoste Drug Sales by Type (2017-2022) & (K Pcs)
Table 51. APAC Herpes Zoste Drug Sales Market Share by Type (2017-2022)
Table 52. APAC Herpes Zoste Drug Sales by Application (2017-2022) & (K Pcs)
Table 53. APAC Herpes Zoste Drug Sales Market Share by Application (2017-2022)
Table 54. Europe Herpes Zoste Drug Sales by Country (2017-2022) & (K Pcs)
Table 55. Europe Herpes Zoste Drug Sales Market Share by Country (2017-2022)
Table 56. Europe Herpes Zoste Drug Revenue by Country (2017-2022) & ($ Millions)
Table 57. Europe Herpes Zoste Drug Revenue Market Share by Country (2017-2022)
Table 58. Europe Herpes Zoste Drug Sales by Type (2017-2022) & (K Pcs)
Table 59. Europe Herpes Zoste Drug Sales Market Share by Type (2017-2022)
Table 60. Europe Herpes Zoste Drug Sales by Application (2017-2022) & (K Pcs)
Table 61. Europe Herpes Zoste Drug Sales Market Share by Application (2017-2022)
Table 62. Middle East & Africa Herpes Zoste Drug Sales by Country (2017-2022) & (K Pcs)
Table 63. Middle East & Africa Herpes Zoste Drug Sales Market Share by Country (2017-2022)
Table 64. Middle East & Africa Herpes Zoste Drug Revenue by Country (2017-2022) & ($ Millions)
Table 65. Middle East & Africa Herpes Zoste Drug Revenue Market Share by Country (2017-2022)
Table 66. Middle East & Africa Herpes Zoste Drug Sales by Type (2017-2022) & (K Pcs)
Table 67. Middle East & Africa Herpes Zoste Drug Sales Market Share by Type (2017-2022)
Table 68. Middle East & Africa Herpes Zoste Drug Sales by Application (2017-2022) & (K Pcs)
Table 69. Middle East & Africa Herpes Zoste Drug Sales Market Share by Application (2017-2022)
Table 70. Key Market Drivers & Growth Opportunities of Herpes Zoste Drug
Table 71. Key Market Challenges & Risks of Herpes Zoste Drug
Table 72. Key Industry Trends of Herpes Zoste Drug
Table 73. Herpes Zoste Drug Raw Material
Table 74. Key Suppliers of Raw Materials
Table 75. Herpes Zoste Drug Distributors List
Table 76. Herpes Zoste Drug Customer List
Table 77. Global Herpes Zoste Drug Sales Forecast by Region (2023-2028) & (K Pcs)
Table 78. Global Herpes Zoste Drug Sales Market Forecast by Region
Table 79. Global Herpes Zoste Drug Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Global Herpes Zoste Drug Revenue Market Share Forecast by Region (2023-2028)
Table 81. Americas Herpes Zoste Drug Sales Forecast by Country (2023-2028) & (K Pcs)
Table 82. Americas Herpes Zoste Drug Revenue Forecast by Country (2023-2028) & ($ millions)
Table 83. APAC Herpes Zoste Drug Sales Forecast by Region (2023-2028) & (K Pcs)
Table 84. APAC Herpes Zoste Drug Revenue Forecast by Region (2023-2028) & ($ millions)
Table 85. Europe Herpes Zoste Drug Sales Forecast by Country (2023-2028) & (K Pcs)
Table 86. Europe Herpes Zoste Drug Revenue Forecast by Country (2023-2028) & ($ millions)
Table 87. Middle East & Africa Herpes Zoste Drug Sales Forecast by Country (2023-2028) & (K Pcs)
Table 88. Middle East & Africa Herpes Zoste Drug Revenue Forecast by Country (2023-2028) & ($ millions)
Table 89. Global Herpes Zoste Drug Sales Forecast by Type (2023-2028) & (K Pcs)
Table 90. Global Herpes Zoste Drug Sales Market Share Forecast by Type (2023-2028)
Table 91. Global Herpes Zoste Drug Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 92. Global Herpes Zoste Drug Revenue Market Share Forecast by Type (2023-2028)
Table 93. Global Herpes Zoste Drug Sales Forecast by Application (2023-2028) & (K Pcs)
Table 94. Global Herpes Zoste Drug Sales Market Share Forecast by Application (2023-2028)
Table 95. Global Herpes Zoste Drug Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 96. Global Herpes Zoste Drug Revenue Market Share Forecast by Application (2023-2028)
Table 97. Astellas Pharma Inc. Basic Information, Herpes Zoste Drug Manufacturing Base, Sales Area and Its Competitors
Table 98. Astellas Pharma Inc. Herpes Zoste Drug Product Offered
Table 99. Astellas Pharma Inc. Herpes Zoste Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 100. Astellas Pharma Inc. Main Business
Table 101. Astellas Pharma Inc. Latest Developments
Table 102. Beijing Minhai Biotechnology Co., Ltd Basic Information, Herpes Zoste Drug Manufacturing Base, Sales Area and Its Competitors
Table 103. Beijing Minhai Biotechnology Co., Ltd Herpes Zoste Drug Product Offered
Table 104. Beijing Minhai Biotechnology Co., Ltd Herpes Zoste Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 105. Beijing Minhai Biotechnology Co., Ltd Main Business
Table 106. Beijing Minhai Biotechnology Co., Ltd Latest Developments
Table 107. ContraVir Pharmaceuticals, Inc. Basic Information, Herpes Zoste Drug Manufacturing Base, Sales Area and Its Competitors
Table 108. ContraVir Pharmaceuticals, Inc. Herpes Zoste Drug Product Offered
Table 109. ContraVir Pharmaceuticals, Inc. Herpes Zoste Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 110. ContraVir Pharmaceuticals, Inc. Main Business
Table 111. ContraVir Pharmaceuticals, Inc. Latest Developments
Table 112. Epiphany Biosciences, Inc. Basic Information, Herpes Zoste Drug Manufacturing Base, Sales Area and Its Competitors
Table 113. Epiphany Biosciences, Inc. Herpes Zoste Drug Product Offered
Table 114. Epiphany Biosciences, Inc. Herpes Zoste Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 115. Epiphany Biosciences, Inc. Main Business
Table 116. Epiphany Biosciences, Inc. Latest Developments
Table 117. Foamix Pharmaceuticals Ltd. Basic Information, Herpes Zoste Drug Manufacturing Base, Sales Area and Its Competitors
Table 118. Foamix Pharmaceuticals Ltd. Herpes Zoste Drug Product Offered
Table 119. Foamix Pharmaceuticals Ltd. Herpes Zoste Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 120. Foamix Pharmaceuticals Ltd. Main Business
Table 121. Foamix Pharmaceuticals Ltd. Latest Developments
Table 122. GeneOne Life Science, Inc. Basic Information, Herpes Zoste Drug Manufacturing Base, Sales Area and Its Competitors
Table 123. GeneOne Life Science, Inc. Herpes Zoste Drug Product Offered
Table 124. GeneOne Life Science, Inc. Herpes Zoste Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 125. GeneOne Life Science, Inc. Main Business
Table 126. GeneOne Life Science, Inc. Latest Developments
Table 127. GlaxoSmithKline Plc Basic Information, Herpes Zoste Drug Manufacturing Base, Sales Area and Its Competitors
Table 128. GlaxoSmithKline Plc Herpes Zoste Drug Product Offered
Table 129. GlaxoSmithKline Plc Herpes Zoste Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 130. GlaxoSmithKline Plc Main Business
Table 131. GlaxoSmithKline Plc Latest Developments
Table 132. Merck & Co., Inc. Basic Information, Herpes Zoste Drug Manufacturing Base, Sales Area and Its Competitors
Table 133. Merck & Co., Inc. Herpes Zoste Drug Product Offered
Table 134. Merck & Co., Inc. Herpes Zoste Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 135. Merck & Co., Inc. Main Business
Table 136. Merck & Co., Inc. Latest Developments
Table 137. NAL Pharmaceuticals Ltd. Basic Information, Herpes Zoste Drug Manufacturing Base, Sales Area and Its Competitors
Table 138. NAL Pharmaceuticals Ltd. Herpes Zoste Drug Product Offered
Table 139. NAL Pharmaceuticals Ltd. Herpes Zoste Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 140. NAL Pharmaceuticals Ltd. Main Business
Table 141. NAL Pharmaceuticals Ltd. Latest Developments
Table 142. ReceptoPharm, Inc. Basic Information, Herpes Zoste Drug Manufacturing Base, Sales Area and Its Competitors
Table 143. ReceptoPharm, Inc. Herpes Zoste Drug Product Offered
Table 144. ReceptoPharm, Inc. Herpes Zoste Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 145. ReceptoPharm, Inc. Main Business
Table 146. ReceptoPharm, Inc. Latest Developments
Table 147. TSRL, Inc. Basic Information, Herpes Zoste Drug Manufacturing Base, Sales Area and Its Competitors
Table 148. TSRL, Inc. Herpes Zoste Drug Product Offered
Table 149. TSRL, Inc. Herpes Zoste Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 150. TSRL, Inc. Main Business
Table 151. TSRL, Inc. Latest Developments
List of Figures
Figure 1. Picture of Herpes Zoste Drug
Figure 2. Herpes Zoste Drug Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Herpes Zoste Drug Sales Growth Rate 2017-2028 (K Pcs)
Figure 7. Global Herpes Zoste Drug Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Herpes Zoste Drug Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Acyclovir
Figure 10. Product Picture of Amenamevir
Figure 11. Product Picture of FV-100
Figure 12. Product Picture of GLS-5100
Figure 13. Product Picture of GSK-1437173A
Figure 14. Product Picture of NAL-3221
Figure 15. Product Picture of Others
Figure 16. Global Herpes Zoste Drug Sales Market Share by Type in 2021
Figure 17. Global Herpes Zoste Drug Revenue Market Share by Type (2017-2022)
Figure 18. Herpes Zoste Drug Consumed in Clinic
Figure 19. Global Herpes Zoste Drug Market: Clinic (2017-2022) & (K Pcs)
Figure 20. Herpes Zoste Drug Consumed in Hospital
Figure 21. Global Herpes Zoste Drug Market: Hospital (2017-2022) & (K Pcs)
Figure 22. Herpes Zoste Drug Consumed in Others
Figure 23. Global Herpes Zoste Drug Market: Others (2017-2022) & (K Pcs)
Figure 24. Global Herpes Zoste Drug Sales Market Share by Application (2017-2022)
Figure 25. Global Herpes Zoste Drug Revenue Market Share by Application in 2021
Figure 26. Herpes Zoste Drug Revenue Market by Company in 2021 ($ Million)
Figure 27. Global Herpes Zoste Drug Revenue Market Share by Company in 2021
Figure 28. Global Herpes Zoste Drug Sales Market Share by Geographic Region (2017-2022)
Figure 29. Global Herpes Zoste Drug Revenue Market Share by Geographic Region in 2021
Figure 30. Global Herpes Zoste Drug Sales Market Share by Region (2017-2022)
Figure 31. Global Herpes Zoste Drug Revenue Market Share by Country/Region in 2021
Figure 32. Americas Herpes Zoste Drug Sales 2017-2022 (K Pcs)
Figure 33. Americas Herpes Zoste Drug Revenue 2017-2022 ($ Millions)
Figure 34. APAC Herpes Zoste Drug Sales 2017-2022 (K Pcs)
Figure 35. APAC Herpes Zoste Drug Revenue 2017-2022 ($ Millions)
Figure 36. Europe Herpes Zoste Drug Sales 2017-2022 (K Pcs)
Figure 37. Europe Herpes Zoste Drug Revenue 2017-2022 ($ Millions)
Figure 38. Middle East & Africa Herpes Zoste Drug Sales 2017-2022 (K Pcs)
Figure 39. Middle East & Africa Herpes Zoste Drug Revenue 2017-2022 ($ Millions)
Figure 40. Americas Herpes Zoste Drug Sales Market Share by Country in 2021
Figure 41. Americas Herpes Zoste Drug Revenue Market Share by Country in 2021
Figure 42. United States Herpes Zoste Drug Revenue Growth 2017-2022 ($ Millions)
Figure 43. Canada Herpes Zoste Drug Revenue Growth 2017-2022 ($ Millions)
Figure 44. Mexico Herpes Zoste Drug Revenue Growth 2017-2022 ($ Millions)
Figure 45. Brazil Herpes Zoste Drug Revenue Growth 2017-2022 ($ Millions)
Figure 46. APAC Herpes Zoste Drug Sales Market Share by Region in 2021
Figure 47. APAC Herpes Zoste Drug Revenue Market Share by Regions in 2021
Figure 48. China Herpes Zoste Drug Revenue Growth 2017-2022 ($ Millions)
Figure 49. Japan Herpes Zoste Drug Revenue Growth 2017-2022 ($ Millions)
Figure 50. South Korea Herpes Zoste Drug Revenue Growth 2017-2022 ($ Millions)
Figure 51. Southeast Asia Herpes Zoste Drug Revenue Growth 2017-2022 ($ Millions)
Figure 52. India Herpes Zoste Drug Revenue Growth 2017-2022 ($ Millions)
Figure 53. Australia Herpes Zoste Drug Revenue Growth 2017-2022 ($ Millions)
Figure 54. Europe Herpes Zoste Drug Sales Market Share by Country in 2021
Figure 55. Europe Herpes Zoste Drug Revenue Market Share by Country in 2021
Figure 56. Germany Herpes Zoste Drug Revenue Growth 2017-2022 ($ Millions)
Figure 57. France Herpes Zoste Drug Revenue Growth 2017-2022 ($ Millions)
Figure 58. UK Herpes Zoste Drug Revenue Growth 2017-2022 ($ Millions)
Figure 59. Italy Herpes Zoste Drug Revenue Growth 2017-2022 ($ Millions)
Figure 60. Russia Herpes Zoste Drug Revenue Growth 2017-2022 ($ Millions)
Figure 61. Middle East & Africa Herpes Zoste Drug Sales Market Share by Country in 2021
Figure 62. Middle East & Africa Herpes Zoste Drug Revenue Market Share by Country in 2021
Figure 63. Egypt Herpes Zoste Drug Revenue Growth 2017-2022 ($ Millions)
Figure 64. South Africa Herpes Zoste Drug Revenue Growth 2017-2022 ($ Millions)
Figure 65. Israel Herpes Zoste Drug Revenue Growth 2017-2022 ($ Millions)
Figure 66. Turkey Herpes Zoste Drug Revenue Growth 2017-2022 ($ Millions)
Figure 67. GCC Country Herpes Zoste Drug Revenue Growth 2017-2022 ($ Millions)
Figure 68. Manufacturing Cost Structure Analysis of Herpes Zoste Drug in 2021
Figure 69. Manufacturing Process Analysis of Herpes Zoste Drug
Figure 70. Industry Chain Structure of Herpes Zoste Drug
Figure 71. Channels of Distribution
Figure 72. Distributors Profiles
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...